Quotient Limited (QTNT) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Quotient Limited  (NASDAQ: QTNT)
 

Quotient Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Quotient Limited inventory turnover ratio, the Quotient Limited's ability to sell and replace its inventory in the third quarter 2023, sequentially increased to 2.09 in the third quarter 2022, QTNT's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Quotient Limited in Dec 31 2022 quarter, has decreased to 175 days, compare to 176 days, in the Sep 30 2022 quarter.

Within Healthcare sector 261 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 1574, from total ranking in the second quarter 2023 at 2039.

QTNT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Quotient Limited Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QTNT Inventory Turnover Ratio (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter
Y / Y Inventory Growth -37.05 % -49 % -4.66 % 0.11 % -4.01 %
Y / Y Cost of Sales Growth -50.76 % 333.17 % 28.11 % 15.39 % 59.52 %
Inventory Turnover Ratio (TTM) 2.09 2.07 1.08 1.01 0.98
QTNT's Total Ranking # 1574 # 2039 # 1949 # 1968 #
Average inventory processing period 175 177 337 360 372
Seq. Inventory Growth 12.3 % -42.22 % 0.21 % -3.18 % -9.01 %
Seq. Cost of Sales Growth -81.51 % 245.05 % 2.17 % -24.45 % 62.63 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 12
Healthcare Sector # 262
Overall Market # 1574

Inventory Turnover Ratio Statistics
High Average Low
2.16 1.12 0.67
(Jun 30 2015)   (Mar 31 2018)



QTNT Company Profile >> Back to QTNT Efficiency Comparisons >> Compare QTNT Inventory Turnover Ratio to its Competitors

Financial Statements
Quotient Limited's Inventories $ 14 Millions Visit QTNT's Balance sheet
Quotient Limited's Cost of Revenues TTM $ 37 Millions Visit QTNT's Income Statement
What are QTNT's Sales? Visit QTNT's Sales by Segment

Other Inventory Turnover Ratios
Quotient Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
QTNT's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for QTNT's Competitors
Inventory Turnover Ratio for QTNT's Suppliers
Inventory Turnover Ratio for QTNT's Customers

You may also want to know
QTNT's Sales Growth Rates QTNT's Pe Price to earnings ratio QTNT's Receivables Turnover Ratio QTNT's Stock Quote
QTNT's Net Income Growth Rates QTNT's Ps Price to Sales ratio QTNT's Sales per Employee QTNT's Asset Turnover Ratio
QTNT's Net Margin QTNT's Pb Price to Book ratio QTNT's Financial Strength Ratios QTNT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2022 Inventories at quarter ending Dec 31 2022
Inogen Inc   6.51 $ 223.708  Millions$ 34  Millions
Adm Tronics Unlimited Inc   6.48 $ 2.254  Millions$ 0  Millions
Agile Therapeutics Inc  6.29 $ 12.836  Millions$ 2  Millions
Hims and Hers Health Inc   6.24 $ 118.194  Millions$ 19  Millions
Sensus Healthcare Inc   6.05 $ 14.904  Millions$ 2  Millions
Fonar Corporation  5.97 $ 14.652  Millions$ 2  Millions
Lifemd Inc   5.89 $ 17.068  Millions$ 3  Millions
Patterson Companies Inc   5.82 $ 5,057.668  Millions$ 869  Millions
Carlisle Companies Incorporated  5.79 $ 4,434.500  Millions$ 766  Millions
Cryoport inc   5.48 $ 133.404  Millions$ 24  Millions
Veracyte Inc   5.47 $ 75.317  Millions$ 14  Millions
Novan Inc   5.45 $ 7.379  Millions$ 1  Millions
Biomerica Inc   5.40 $ 13.491  Millions$ 2  Millions
Avantor Inc   5.40 $ 4,909.600  Millions$ 909  Millions
Collegium Pharmaceutical Inc   5.36 $ 360.885  Millions$ 67  Millions
Ufp Technologies Inc   5.24 $ 263.532  Millions$ 50  Millions
Cti Biopharma Corp   5.24 $ 3.514  Millions$ 1  Millions
Neptune Wellness Solutions Inc   5.22 $ 48.207  Millions$ 9  Millions
Burning Rock Biotech Limited  5.19 $ 26.561  Millions$ 5  Millions
Integer Holdings Corporation  5.17 $ 1,017.090  Millions$ 197  Millions
Abbvie Inc   5.11 $ 17,414.000  Millions$ 3,408  Millions
Exact Sciences Corporation  4.98 $ 574.394  Millions$ 115  Millions
Lftd Partners Inc   4.79 $ 33.933  Millions$ 7  Millions
Harrow Inc   4.76 $ 25.383  Millions$ 5  Millions
Henry Schein Inc   4.72 $ 8,816.000  Millions$ 1,869  Millions
Bristol myers Squibb Company  4.68 $ 10,137.000  Millions$ 2,165  Millions
Horizon Therapeutics Public Limited Company  4.66 $ 920.197  Millions$ 198  Millions
Incyte Corporation  4.66 $ 206.997  Millions$ 44  Millions
Catalyst Pharmaceuticals Inc   4.65 $ 34.393  Millions$ 7  Millions
Sanuwave Health Inc   4.64 $ 4.883  Millions$ 1  Millions

Date modified: 2026-09-08T15:22:10+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.